Methionine-driven methylation modification overcomes plasmid-mediated high-level tigecycline resistance
Abstract Tigecycline is a last-resort antibiotic to treat complicated infections caused by multidrug-resistant pathogens, while the emergence of plasmid-mediated tet(X) family severely compromises its clinical efficacy. Novel antimicrobial strategies not limited to new antibiotics in pharmaceutical...
Saved in:
Main Authors: | Dan Fang, Tianqi Xu, Fulei Li, Yue Sun, Jingyi Sun, Yanqing Yin, Haijie Zhang, Zhiqiang Wang, Yuan Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55791-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUCCESSFUL TREATMENT OF PERIPROSTHESIS INFECTION BY TIGECYCLINE
by: S. K. Yarovoy, et al.
Published: (2015-04-01) -
Identification of RNA Editing Sites Reveals Functional Modifications with the Addition of Methionine to the Daily Rations of Yaks
by: Shiyu Wu, et al.
Published: (2025-01-01) -
Immunomodulatory Effects of Tigecycline in Balb/C Mice
by: Elhayek Shada Y., et al.
Published: (2018-12-01) -
Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
by: Sertan Goktas, et al.
Published: (2014-01-01) -
Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
by: Charles H. Halsted, et al.
Published: (2012-01-01)